The company
Hyperfine, Inc.
HYPR · Nasdaq
HYPR stood above a rising 150-day average in 15 of the last 52 weekly readings, and has been out of that trend for the last 15 weeks. It is 32.4% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 15
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $185K
- Officials’ trades on record
- 0
- Institutions holding
- 80 (+32)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Brett HaleCFO and CAO | sold | 7,345at $0.854 | 24 Aug 2026filed 25 Aug 2026 |
| Thomas TeisseyreChief Operating Officer | sold | 7,345at $0.854 | 24 Aug 2026filed 25 Aug 2026 |
| Thomas TeisseyreChief Operating Officer | sold | 6,047at $1.65 | 26 May 2026filed 27 May 2026 |
| Brett HaleCFO and CAO | sold | 6,047at $1.65 | 26 May 2026filed 27 May 2026 |
| Brett HaleCFO and CAO | sold | 24,188at $1.21 | 23 Mar 2026filed 25 Mar 2026 |
| Thomas TeisseyreChief Operating Officer | sold | 24,188at $1.21 | 23 Mar 2026filed 25 Mar 2026 |
| Thomas TeisseyreChief Operating Officer | sold | 821at $1.11 | 13 Feb 2026filed 17 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,673,087$6.3M | +4,098,184+712.8% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 3,380,087$4.6M | -73,076−2.1% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,960,811$2.6M | +1,005,551+105.3% |
| Fosun International Ltdunchanged · filed 12 Aug 2026 | 1,742,020$2.4M | 00.0% |
| Catalio Capital Management, LPunchanged · filed 14 Aug 2026 | 1,320,041$1.8M | 00.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 1,016,970$1.4M | +692,900+213.8% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 945,836$1.3M | +215,603+29.5% |
| Alphabet Inc.unchanged · filed 7 Aug 2026 | 898,720$1.2M | 00.0% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 633,054$855K | +455,686+256.9% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 567,109$766K | +40,403+7.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.